Sigh of relief, definitely. I am still smarting from the...

Sigh of relief, definitely.

I am still smarting from the absolute smacking we took when srAGvHD, CHF, CLBP and COVID ARDS were all sent packing within a few months of each other a few years back. I have continued to add, and averaged down over the last few years, and am now down to only $2.07, but I am still hundreds of thousands of dollars in the red, so just being back to even, or somewhere close to that will feel like a massive win, and like justice is finally being done for SI, for LTSHs, and especially, for patients that need--yes NEED--these treatments to survive.

I expect that the share-buying public will take some time to warm to MSB, even after this initial approval (particularly if it's an nuanced approval that still requires hard work on MSB's part), and that our shorting pests will stick around and try to continue poking holes in the MSB story for their own selfish ends.

Haven't decided if I should sell any on the news if it hits around $4 dollars or so, just to lock in some profits. Part of me is too masochistic to give up anything when the next good bit of news might just be a few months off, but I guess I can always buy those shares back and just not make as much.

Decisions, decisions.